Supplementary Figure S5 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S5. Change in SUVmax in patients with
Supplementary Figure S5 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma | Synapse